StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Earnings

Ensysce Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 29, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$4.52
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Ensysce Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 29, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close––-$4.52Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026after the close––-$0.20Release
Q1 FY2026ended Mar 31, 2026May 15, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Mar 30, 2026after the close––-$0.75Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close––-$0.79Release
Q1 FY2025ended Mar 31, 2025May 13, 2025after the close––-$1.39Release
Q4 FY2024ended Dec 31, 2024Mar 10, 2025after the close––-$2.90Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024after the close––-$0.22Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open––-$0.55Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Ensysce Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Ensysce Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Ensysce Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Results
  6. News
  7. Results
  8. News
  9. Results
  10. Results
  11. Results
  12. News
  13. News
  14. Results
  15. Results

See a number that looks wrong?